US FDA requires ‘boxed warning’ on CAR-T cancer therapies

A US health regulator on Monday asked a slew of drug makers, including Gilead Sciences, Johnson & Johnson and Novartis, to add a strong warning to the label of their cancer therapies that use CAR-T technology. 

Share This Post:

POPULAR POSTS
FOLLOW US
Like Us On Facebook
Follow Us On Twitter
Subscribe To Our Channel
TikTok
LIVE STREAM